natgillin/translations-raw huggingface dataset:
Rivaroxaban pharmacokinetics are approximately linear up to about 15 mg once daily in fasting state.
Farmakokinetika rivaroksabana na tešče je skoraj linearna do odmerka približno 15 mg enkrat na dan.
Rivastigmine
0,0021
Rivastigmine
Rivastigmin 13,3 mg/24 h
Rivastigmine
Rivastigmin 9,5 mg/24 h
Rivastigmine 1 A Pharma 1.5 mg [folding box only]
Rivastigmin 1 A Pharma 1,5 mg [samo na škatli]
Rivastigmine 1 A Pharma 1.5 mg hard capsules Rivastigmine
Rivastigmin 1 A Pharma 1,5 mg trde kapsule rivastigmin
Rivastigmine 1 A Pharma 1.5 mg hard capsules Rivastigmine 1 A Pharma 3 mg hard capsules Rivastigmine 1 A Pharma 4.5 mg hard capsules Rivastigmine 1 A Pharma 6 mg hard capsules
Rivastigmin 1 A Pharma 1,5 mg trde kapsule Rivastigmin 1 A Pharma 3 mg trde kapsule Rivastigmin 1 A Pharma 4,5 mg trde kapsule Rivastigmin 1 A Pharma 6 mg trde kapsule
Rivastigmine 1 A Pharma 1.5 mg hard capsules Rivastigmine 1 A Pharma 3 mg hard capsules Rivastigmine 1 A Pharma 4.5 mg hard capsules Rivastigmine 1 A Pharma 6 mg hard capsules Rivastigmine
Rivastigmin 1 A Pharma 1,5 mg trde kapsule Rivastigmin 1 A Pharma 3 mg trde kapsule Rivastigmin 1 A Pharma 4,5 mg trde kapsule Rivastigmin 1 A Pharma 6 mg trde kapsule rivastigmin
Rivastigmine 1 A Pharma 1.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a yellow cap and yellow body, with a red imprint “RIV 1.5 mg” on the body.
Rivastigmin 1 A Pharma 1,5 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rumen pokrovček in rumeno telo kapsule z rdečim napisom “RIV 1,5 mg”.
Rivastigmine 1 A Pharma 2 mg/ml [folding box only]
Rivastigmin 1A Pharma 2 mg/ml [samo na škatli]
Rivastigmine 1 A Pharma 2 mg/ml oral solution Rivastigmine
Rivastigmin 1 A Pharma 2 mg/ml peroralna raztopina rivastigmin
Rivastigmine 1 A Pharma 3 mg [folding box only]
Rivastigmin 1 A Pharma 3 mg [samo na škatli]
Rivastigmine 1 A Pharma 3 mg hard capsules Rivastigmine
Rivastigmin 1 A Pharma 3 mg trde kapsule rivastigmin
Rivastigmine 1 A Pharma 3 mg hard capsules, which contain an off-white to slightly yellow powder, have an orange cap and orange body, with a red imprint “RIV 3 mg” on the body.
Rivastigmin 1 A Pharma 3 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo oranžen pokrovček in oranžno telo kapsule z rdečim napisom “RIV 3 mg”.
Rivastigmine 1 A Pharma 4.5 mg [folding box only]
Rivastigmin 1 A Pharma 4,5 mg [samo na škatli]
Rivastigmine 1 A Pharma 4.5 mg hard capsules Rivastigmine
Rivastigmin 1 A Pharma 4,5 mg trde kapsule rivastigmin
Rivastigmine 1 A Pharma 4.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and red body, with a white imprint “RIV 4.5 mg” on the body.
Rivastigmin 1 A Pharma 4,5 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rdeč pokrovček in rdeče telo kapsule z belim napisom “RIV 4,5 mg”.
Rivastigmine 1 A Pharma 6 mg hard capsules Rivastigmine
Rivastigmin 1 A Pharma 6 mg trde kapsule rivastigmin
Rivastigmine 1 A Pharma 6 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and orange body, with a red imprint “RIV 6 mg” on the body.
Rivastigmin 1 A Pharma 6 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rdeč pokrovček in oranžno telo kapsule z rdečim napisom “RIV 6 mg”.
Rivastigmine 1 A Pharma 6 mg[folding box only]
Rivastigmin 1 A Pharma 6 mg [samo na škatli]
Rivastigmine 1 A Pharma has been studied in three main studies involving 2,126 patients with mild to moderately severe Alzheimer’s disease.
Zdravilo Rivastigmine 1 A Pharma so proučevali v treh glavnih študijah, v katerih je sodelovalo 2 126 bolnikov z blago do zmerno hudo obliko Alzheimerjeve bolezni.
Rivastigmine 1 A Pharma is also used to treat mild to moderately severe dementia in patients with Parkinson’s disease.
Zdravilo se lahko uporablja tudi za zdravljenje blage do zmerno hude demence pri bolnikih s Parkinsonovo boleznijo.
Rivastigmine 1 A Pharma is used for the treatment of patients with mild to moderately severe Alzheimer’s dementia, a progressive brain disorder that gradually affects memory, intellectual ability and behaviour.
Zdravilo Rivastigmine 1 A Pharma se uporablja za zdravljenje bolnikov z blago do zmerno hudo Alzheimerjevo demenco, tj. napredujočo okvaro možganov, ki postopoma prizadene spomin, intelektualne zmožnosti in vedenje.
Rivastigmine 1 A Pharma might interfere with anticholinergic medicines (medicines used to relieve stomach cramps or spasms, to treat Parkinson’s disease or to prevent travel sickness).
Zdravilo Rivastigmin 1 A Pharma bi lahko vplivalo na zdravljenje z antiholinergičnimi zdravili (zdravili, ki se uporabljajo za lajšanje želodčnih krčev ali spazmov, za zdravljenje Parkinsonove bolezni ali za preprečevanje slabosti na potovanju).
Rivastigmine 1 A Pharma oral solution should be used within 1 month of opening the bottle.
Peroralno raztopino Rivastigmin 1 A Pharma je treba porabiti v enem mesecu po prvem odprtju steklenice.
Rivastigmine 1 A Pharma rivastigmine
Rivastigmine 1 A Pharma rivastigmin
Rivastigmine 1 A Pharma should not be used during pregnancy unless clearly necessary.
Zdravila Rivastigmin 1 A Pharma v času nosečnosti ne smete uporabljati, če to ni nujno potrebno.
Rivastigmine 1 A Pharma was also studied in 541 patients with dementia due to Parkinson’s disease.
Zdravilo Rivastigmine 1 A Pharma so proučevali tudi pri 541 bolnikih z demenco kot posledico Parkinsonove bolezni.
Rivastigmine 3M Health Care Ltd is a ‘generic medicine’.
Zdravilo Rivastigmin 3M Health Care Ltd je „generično zdravilo“.
Rivastigmine 3M Health Care Ltd is used to treat patients with mild to moderately severe Alzheimer’s dementia, a progressive brain disorder that gradually affects memory, intellectual ability and behaviour.
Uporablja se za zdravljenje bolnikov z blago do zmerno hudo Alzheimerjevo demenco, tj. napredujočo možgansko boleznijo, ki postopoma prizadene spomin, intelektualno sposobnost in vedenje.
Rivastigmine 3M Health Care Ltd rivastigmine
Rivastigmin 3M Health Care Ltd rivastigmin
Rivastigmine 3M Health Care Ltd.
Rivastigmin 3M
Rivastigmine 3M Health Care Ltd. might interfere with anticholinergic medicines some of which are medicines used to relieve stomach cramps or spasms (e.g. dicyclomine), to treat Parkinson’s disease (e.g. amantadine) or to prevent motion sickness (e.g. diphenhydramine, scopolamine or meclizine).
Zdravilo Rivastigmin 3M Health Care Ltd. lahko vpliva na antiholinergična zdravila, med katera sodijo zdravila, ki se uporabljajo za lajšanje želodčnih krčev (npr. diciklomin), za zdravljenje Parkinsonove bolezni (npr. amantadin) ali za preprečevanje potovalne slabosti (npr. difenhidramin, skopolamin ali meklizin).
Rivastigmine 3M Health Care Ltd. patches are transparent to translucent, plastic patches that stick to the skin.
Obliži Rivastigmin 3M Health Care Ltd. so prozorni ali prosojni plastični obliži, ki jih prilepite na kožo.
Rivastigmine 3M Health Care Ltd. should not be used during pregnancy unless clearly necessary.
Zdravila Rivastigmin 3M Health Care Ltd. v času nosečnosti ne smete uporabljati, če to ni nujno potrebno.
Rivastigmine 6-12 mg N=379
rivastigmin 6-12 mg
Rivastigmine 6-12 mg N=473
rivastigmin 6-12 mg
Rivastigmine 6–12 mg N=379
Rivastigmin 6-12 mg
Rivastigmine 6–12 mg N=379
Rivastigmin 6–12 mg
Rivastigmine 6–12 mg N=473
Rivastigmin 6-12 mg
Rivastigmine 6–12 mg N=473
Rivastigmin 6–12 mg
Rivastigmine Actavis 1.5 mg capsules rivastigmine
Rivastigmin Actavis 1,5 mg trde kapsule rivastigmin
Rivastigmine Actavis 1.5 mg hard capsules rivastigmine
Rivastigmin Actavis 1,5 mg trde kapsule rivastigmin
Rivastigmine Actavis 1.5 mg hard capsules Rivastigmine Actavis 3 mg hard capsules Rivastigmine Actavis 4.5 mg hard capsules Rivastigmine Actavis 6 mg hard capsules
Rivastigmin Actavis 1,5 mg trde kapsule Rivastigmin Actavis 3 mg trde kapsule Rivastigmin Actavis 4,5 mg trde kapsule Rivastigmin Actavis 6 mg trde kapsule
Rivastigmine Actavis 1.5 mg hard capsules, which contain off-white to slightly yellow powder, have a yellow cap and yellow body, with red imprint “RIV 1.5mg” on body.
Rivastigmin Actavis 1,5 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rumen pokrovček in rumeno telo z rdečim napisom “RIV 1,5mg” na telesu.
Rivastigmine Actavis 3 mg capsules rivastigmine
Rivastigmin Actavis 3 mg trde kapsule rivastigmin
Rivastigmine Actavis 3 mg hard capsules rivastigmine
Rivastigmin Actavis 3 mg trde kapsule rivastigmin
Rivastigmine Actavis 3 mg hard capsules, which contain off-white to slightly yellow powder, have an orange cap and orange body, with red imprint “RIV 3mg” on body.
Rivastigmin Actavis 3 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo oranžen pokrovček in oranžno telo z rdečim napisom “RIV 3mg” na telesu.
Rivastigmine Actavis 4.5 mg capsules rivastigmine
Rivastigmin Actavis 4,5 mg trde kapsule rivastigmin
Rivastigmine Actavis 4.5 mg hard capsules rivastigmine
Rivastigmin Actavis 4,5 mg trde kapsule rivastigmin
Rivastigmine Actavis 4.5 mg hard capsules, which contain off-white to slightly yellow powder, have a red cap and red body, with white imprint “RIV 4.5mg” on body.
Rivastigmin Actavis 4,5 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rdeč pokrovček in rdeče telo z belim napisom “RIV 4,5mg” na telesu.
Rivastigmine Actavis 6 mg capsules rivastigmine
Rivastigmin Actavis 6 mg trde kapsule rivastigmin
Rivastigmine Actavis 6 mg hard capsules rivastigmine
Rivastigmin Actavis 6 mg trde kapsule rivastigmin
Rivastigmine Actavis 6 mg hard capsules, which contain off -white to slightly yellow powder, have an red cap and orange body, with red imprint “RIV 6mg” on body.
Rivastigmin Actavis 6 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rdeč pokrovček in oranžno telo z rdečim napisom “RIV 6mg” na telesu.
Rivastigmine Actavis is a ‘generic medicine’.
Rivastigmine Actavis je „generično zdravilo“.
Rivastigmine Actavis is used for the treatment of adult patients with mild to moderately severe Alzheimer’s dementia, a progressive brain disorder that gradually affects memory, intellectual ability and behaviour.
Zdravilo Rivastigmin Actavis uporabljamo za zdravljenje odraslih bolnikov z blago do zmerno hudo Alzheimerjevo demenco, to je napredujoča bolezen možganov, ki postopoma prizadene spomin in intelektualne sposobnosti ter vpliva na vedenje bolnika.
Rivastigmine Actavis is used for the treatment of patients with mild to moderately severe Alzheimer’s dementia, a progressive brain disorder that gradually affects memory, intellectual ability and behaviour.
Zdravilo Rivastigmine Actavis se uporablja za zdravljenje bolnikov z blago do zmerno hudo alzheimerjevo demenco, tj. napredujočo okvaro možganov, ki postopoma prizadene spomin, intelektualne zmožnosti in vedenje.
Rivastigmine Actavis might interfere with anticholinergic medicines (medicines used to relieve stomach cramps or spasms, to treat Parkinson’s disease or to prevent travel sickness).
Zdravilo Rivastigmin Actavis bi lahko vplivalo na zdravljenje z antiholinergičnimi zdravili (zdravili, ki se uporabljajo za lajšanje želodčnih krčev ali spazmov, za zdravljenje Parkinsonove bolezni ali za preprečevanje slabosti na potovanju).
Rivastigmine Actavis should not be used during pregnancy, unless clearly necessary.
Zdravila Rivastigmin Actavis v času nosečnosti ne smete uporabljati, če to ni nujno potrebno.
Rivastigmine capsules
Rivastigmin kapsule
Rivastigmine HEXAL 1.5 mg [folding box only]
Rivastigmin HEXAL 1,5 mg [samo na škatli]
Rivastigmine HEXAL 1.5 mg hard capsules Rivastigmine
Rivastigmin HEXAL 1,5 mg trde kapsule rivastigmin
Rivastigmine HEXAL 1.5 mg hard capsules Rivastigmine HEXAL 3 mg hard capsules Rivastigmine HEXAL 4.5 mg hard capsules Rivastigmine HEXAL 6 mg hard capsules Rivastigmine
Rivastigmin HEXAL 1,5 mg trde kapsule Rivastigmin HEXAL 3 mg trde kapsule Rivastigmin HEXAL 4,5 mg trde kapsule Rivastigmin HEXAL 6 mg trde kapsule rivastigmin
Rivastigmine HEXAL 1.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a yellow cap and yellow body, with a red imprint “RIV 1.5 mg” on the body.
Rivastigmin HEXAL 1,5 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rumen pokrovček in rumeno telo kapsule z rdečim napisom “RIV 1,5 mg”.
Rivastigmine HEXAL 1.5 mg hard capsules: EU/1/09/589/001
Rivastigmin HEXAL 1,5 mg trde kapsule: EU/1/09/589/001
Rivastigmine HEXAL 2 mg/ml [folding box only]
Rivastigmin HEXAL 2 mg/ml [samo na škatli]
Rivastigmine HEXAL 2 mg/ml oral solution Rivastigmine
Rivastigmin HEXAL 2 mg/ml peroralna raztopina rivastigmin
Rivastigmine HEXAL 3 mg [folding box only]
Rivastigmin HEXAL 3 mg [samo na škatli]
Rivastigmine HEXAL 3 mg hard capsules Rivastigmine
Rivastigmin HEXAL 3 mg trde kapsule rivastigmin
Rivastigmine HEXAL 3 mg hard capsules, which contain an off-white to slightly yellow powder, have an orange cap and orange body, with a red imprint “RIV 3 mg” on the body.
Rivastigmin HEXAL 3 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo oranžen pokrovček in oranžno telo kapsule z rdečim napisom “RIV 3 mg”.
Rivastigmine HEXAL 3 mg hard capsules: EU/1/09/589/005
Rivastigmin HEXAL 3 mg trde kapsule: EU/1/09/589/005
Rivastigmine HEXAL 4.5 mg [folding box only]
Rivastigmin HEXAL 4,5 mg [samo na škatli]
Rivastigmine HEXAL 4.5 mg hard capsules Rivastigmine
Rivastigmin HEXAL 4,5 mg trde kapsule rivastigmin
Rivastigmine HEXAL 4.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and red body, with a white imprint “RIV 4.5 mg” on the body.
Rivastigmin HEXAL 4,5 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rdeč pokrovček in rdeče telo kapsule z belim napisom “RIV 4,5 mg”.
Rivastigmine HEXAL 4.5 mg hard capsules:
Rivastigmin HEXAL 4,5 mg trde kapsule: EU/1/09/589/009
Rivastigmine HEXAL 6 mg hard capsules Rivastigmine
Rivastigmin HEXAL 6 mg trde kapsule rivastigmin
Rivastigmine HEXAL 6 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and orange body, with a red imprint “RIV 6 mg” on the body.
Rivastigmin HEXAL 6 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rdeč pokrovček in oranžno telo kapsule z rdečim napisom “RIV 6 mg”.
Rivastigmine HEXAL 6 mg hard capsules: EU/1/09/589/013
Rivastigmin HEXAL 6 mg trde kapsule: EU/1/09/589/013
Rivastigmine HEXAL 6 mg[folding box only]
Rivastigmin HEXAL 6 mg [samo na škatli]
Rivastigmine Hexal has been studied in three main studies involving 2,126 patients with mild to moderately severe Alzheimer’s disease.
Zdravilo Rivastigmine Hexal so proučevali v treh glavnih študijah, v katerih je sodelovalo 2 126 bolnikov z blago do zmerno hudo obliko Alzheimerjeve bolezni.
Rivastigmine Hexal is also used to treat mild to moderately severe dementia in patients with Parkinson’s disease.
Zdravilo se lahko uporablja tudi za zdravljenje blage do zmerno hude demence pri bolnikih s Parkinsonovo boleznijo.
Rivastigmine Hexal is used for the treatment of patients with mild to moderately severe Alzheimer’s dementia, a progressive brain disorder that gradually affects memory, intellectual ability and behaviour.
Zdravilo Rivastigmine Hexal se uporablja za zdravljenje bolnikov z blago do zmerno hudo Alzheimerjevo demenco, tj. napredujočo okvaro možganov, ki postopoma prizadene spomin, intelektualne zmožnosti in vedenje.
Rivastigmine HEXAL might interfere with anticholinergic medicines (medicines used to relieve stomach cramps or spasms, to treat Parkinson’s disease or to prevent travel sickness).
Zdravilo Rivastigmin HEXAL bi lahko vplivalo na zdravljenje z antiholinergičnimi zdravili (zdravili, ki se uporabljajo za lajšanje želodčnih krčev ali spazmov, za zdravljenje Parkinsonove bolezni ali za preprečevanje slabosti na potovanju).
Rivastigmine HEXAL oral solution should be used within 1 month of opening the bottle.
Peroralno raztopino Rivastigmin HEXAL je treba porabiti v enem mesecu po prvem odprtju steklenice.
Rivastigmine Hexal rivastigmine
Rivastigmine Hexal rivastigmin
Rivastigmine HEXAL should not be used during pregnancy unless clearly necessary
Zdravila Rivastigmin HEXAL v času nosečnosti ne smete uporabljati, če to ni nujno potrebno.
Rivastigmine HEXAL should not be used during pregnancy unless clearly necessary.
Zdravila Rivastigmin HEXAL v času nosečnosti ne smete uporabljati, če to ni nujno potrebno.
Rivastigmine Hexal was also studied in 541 patients with dementia due to Parkinson’s disease.
Zdravilo Rivastigmine Hexal so proučevali tudi pri 541 bolnikih z demenco kot posledico Parkinsonove bolezni.
Rivastigmine in vivo release rates per 24 h
hitrost sproščanja rivastigmina na 24 ur in vivo
Rivastigmine interacts with its target enzymes by forming a covalently bound complex that temporarily inactivates the enzymes.
Rivastigmin učinkuje na svoje ciljne encime tako, da tvori kovalentni kompleks, in jih začasno inaktivira.
Rivastigmine is an acetyl- and butyrylcholinesterase inhibitor of the carbamate type, thought to facilitate cholinergic neurotransmission by slowing the degradation of acetylcholine released by functionally intact cholinergic neurones.
Rivastigmin je zaviralec acetil- in butirilholinesteraze karbamatnega tipa, za katerega menijo, da pomaga pri holinergični nevrotransmisiji tako, da upočasni razgradnjo acetilholina, ki ga sproščajo funkcionalno intaktni holnergični nevroni.
Rivastigmine is known to induce bradycardia which constitutes a risk factor of QT prolongation and post-marketing cases of cardiac arrhythmia have been reported with the use of rivastigmine, especially in patients with other risk factors for QTc prolongation / Torsade de pointes (TdP) (concomitant treatments known to induce TdP, relevant cardiac disorders).
Za rivastigmin je znano, da povzroča bradikardijo, ki predstavlja dejavnik tveganja za podaljšanje intervala QT, pa tudi po prihodu zdravila na trg so poročali o primerih aritmije pri uporabi rivastigmina, zlasti pri bolnikih s prisotnimi drugimi dejavniki tveganja za podaljšanje intervala QT oziroma razvoj torsade de pointes (ob sočasni uporabi drugih zdravil, za katera je znano, da lahko sprožijo torsade de pointes, oziroma ob prisotnih drugih s tem povezanih boleznih srca).
Rivastigmine is not recommended for use in children.
Uporaba rivastigmina pri otrocih ni priporočljiva.
Rivastigmine is rapidly and extensively metabolised (half-life in plasma approximately 1 hour), primarily via cholinesterase-mediated hydrolysis to the decarbamylated metabolite.
Rivastigmin se hitro in obsežno presnavlja (razpolovni čas v plazmi je približno 1 ura), primarno s
Rivastigmine might interfere with the activity of anticholinergic medicinal products (e.g oxybutynin, tolterodine).
Rivastigmin lahko moti delovanje antiholinergikov (na primer oksibutinina in tolterodina)..
Rivastigmine orodispersible tablets may be used as an alternative to rivastigmine capsules.
Orodisperzibilne tablete rivastigmina so alternativa kapsulam.
Rivastigmine Sandoz 1.5 mg [folding box only]
Rivastigmin Sandoz 1,5 mg [samo na škatli]
Rivastigmine Sandoz 1.5 mg hard capsules Rivastigmine
Rivastigmin Sandoz 1,5 mg trde kapsule rivastigmin
Rivastigmine Sandoz 1.5 mg hard capsules Rivastigmine Sandoz 3 mg hard capsules Rivastigmine Sandoz 4.5 mg hard capsules Rivastigmine Sandoz 6 mg hard capsules Rivastigmine
Rivastigmin Sandoz 1,5 mg trde kapsule Rivastigmin Sandoz 3 mg trde kapsule Rivastigmin Sandoz 4,5 mg trde kapsule Rivastigmin Sandoz 6 mg trde kapsule rivastigmin
Rivastigmine Sandoz 1.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a yellow cap and yellow body, with a red imprint “RIV 1.5 mg” on the body.
Rivastigmin Sandoz 1,5 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rumen pokrovček in rumeno telo kapsule z rdečim napisom “RIV 1,5 mg”.
Rivastigmine Sandoz 1.5 mg hard capsules: EU/1/09/599/001
Rivastigmin Sandoz 1,5 mg trde kapsule: EU/1/09/599/001
Rivastigmine Sandoz 2 mg/ml [folding box only]
Rivastigmin Sandoz 2 mg/ml [samo na škatli]
Rivastigmine Sandoz 2 mg/ml oral solution Rivastigmine
Rivastigmin Sandoz 2 mg/ml peroralna raztopina rivastigmin
Rivastigmine Sandoz 3 mg [folding box only]
Rivastigmin Sandoz 3 mg [samo na škatli]
Rivastigmine Sandoz 3 mg hard capsules Rivastigmine
Rivastigmin Sandoz 3 mg trde kapsule rivastigmin
Rivastigmine Sandoz 3 mg hard capsules, which contain an off-white to slightly yellow powder, have an orange cap and orange body, with a red imprint “RIV 3 mg” on the body.
Rivastigmin Sandoz 3 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo oranžen pokrovček in oranžno telo kapsule z rdečim napisom “RIV 3 mg”.
Rivastigmine Sandoz 3 mg hard capsules: EU/1/09/599/005
Rivastigmin Sandoz 3 mg trde kapsule: EU/1/09/599/005
Rivastigmine Sandoz 4.5 mg [folding box only]
Rivastigmin Sandoz 4,5 mg [samo na škatli]
Rivastigmine Sandoz 4.5 mg hard capsules Rivastigmine
Rivastigmin Sandoz 4,5 mg trde kapsule rivastigmin
Rivastigmine Sandoz 4.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and red body, with a white imprint “RIV 4.5 mg” on the body.
Rivastigmin Sandoz 4,5 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rdeč pokrovček in rdeče telo kapsule z belim napisom “RIV 4,5 mg”.
Rivastigmine Sandoz 4.5 mg hard capsules: EU/1/09/599/009
Rivastigmin Sandoz 4,5 mg trde kapsule: EU/1/09/599/009
Rivastigmine Sandoz 6 mg hard capsules Rivastigmine
Rivastigmin Sandoz 6 mg trde kapsule rivastigmin
Rivastigmine Sandoz 6 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and orange body, with a red imprint “RIV 6 mg” on the body.
Rivastigmin Sandoz 6 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rdeč pokrovček in oranžno telo kapsule z rdečim napisom “RIV 6 mg”.
Rivastigmine Sandoz 6 mg hard capsules: EU/1/09/599/013
Rivastigmin Sandoz 6 mg trde kapsule: EU/1/09/599/013
Rivastigmine Sandoz 6 mg[folding box only]
Rivastigmin Sandoz 6 mg [samo na škatli]
Rivastigmine Sandoz has been studied in three main studies involving 2,126 patients with mild to moderately severe Alzheimer’s disease.
Zdravilo Rivastigmine Sandoz so proučevali v treh glavnih študijah, v katerih je sodelovalo 2 126 bolnikov z blago do zmerno hudo obliko Alzheimerjeve bolezni.
Rivastigmine Sandoz is also used to treat mild to moderately severe dementia in patients with Parkinson’s disease.
Zdravilo se lahko uporablja tudi za zdravljenje blage do zmerno hude demence pri bolnikih s Parkinsonovo boleznijo.
Rivastigmine Sandoz is used for the treatment of patients with mild to moderately severe Alzheimer’s dementia, a progressive brain disorder that gradually affects memory, intellectual ability and behaviour.
Zdravilo Rivastigmine Sandoz se uporablja za zdravljenje bolnikov z blago do zmerno hudo Alzheimerjevo demenco, tj. napredujočo okvaro možganov, ki postopoma prizadene spomin, intelektualne zmožnosti in vedenje.
Rivastigmine Sandoz may cause dizziness and somnolence, mainly at the start of treatment or when increasing the dose.
Zdravilo Rivastigmin Sandoz lahko povzroči vrtoglavost in zaspanost, predvsem na začetku zdravljenja ali ob povečanju odmerka.
Rivastigmine Sandoz might interfere with anticholinergic medicines (medicines used to relieve stomach cramps or spasms, to treat Parkinson’s disease or to prevent travel sickness).
Zdravilo Rivastigmin Sandoz bi lahko vplivalo na zdravljenje z antiholinergičnimi zdravili (zdravili, ki se uporabljajo za lajšanje želodčnih krčev ali spazmov, za zdravljenje Parkinsonove bolezni ali za preprečevanje slabosti na potovanju).
Rivastigmine Sandoz oral solution should be used within 1 month of opening the bottle.
Peroralno raztopino Rivastigmin Sandoz je treba porabiti v enem mesecu po prvem odprtju steklenice.
Rivastigmine Sandoz rivastigmine
Rivastigmine Sandoz rivastigmin
Rivastigmine Sandoz should not be used during pregnancy unless clearly necessary.
Zdravila Rivastigmin Sandoz v času nosečnosti ne smete uporabljati, če to ni nujno potrebno.
Rivastigmine Sandoz was also studied in 541 patients with dementia due to Parkinson’s disease.
Zdravilo Rivastigmine Sandoz so proučevali tudi pri 541 bolnikih z demenco kot posledico Parkinsonove bolezni.
Rivastigmine Teva 1.5 mg hard capsules
Rivastigmine Teva 1,5 mg trde kapsule